Bellevue Group Ag Mersana Therapeutics, Inc. Transaction History

Bellevue Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $848 - $3,128	-800 Reduced 0.02%	5,218,625 $6.63 Million
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $2.83 Million - $8.78 Million	919,806 Added 21.39%	5,219,425 $17.2 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $68,076 - $119,473	17,019 Added 0.4%	4,299,619 $17.7 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $1.13 Million - $1.57 Million	200,000 Added 4.9%	4,282,600 $25.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $867,662 - $1.5 Million	187,400 Added 4.81%	4,082,600 $27.6 Million
Q2 2022 Aug 11, 2022	SELL	$2.84 - $5.0 $166,992 - $294,000	-58,800 Reduced 1.49%	3,895,200 $18 Million
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $785,400 - $1.39 Million	-210,000 Reduced 5.04%	3,954,000 $15.8 Million
Q4 2021 Feb 10, 2022	SELL	$5.48 - $9.86 $531,560 - $956,420	-97,000 Reduced 2.28%	4,164,000 $25.9 Million
Q3 2021 Nov 12, 2021	BUY	$8.56 - $14.47 $11.3 Million - $19.1 Million	1,320,000 Added 44.88%	4,261,000 $40.2 Million
Q2 2021 Aug 12, 2021	BUY	$13.28 - $18.07 $1.21 Million - $1.64 Million	90,990 Added 3.19%	2,941,000 $39.9 Million
Q1 2021 May 12, 2021	BUY	$15.31 - $26.52 $14.1 Million - $24.5 Million	924,000 Added 47.97%	2,850,010 $46.1 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $32.4 Million - $53.1 Million	1,926,010 New	1,926,010 $51.3 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.